Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT00415233
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed differentiated thyroid cancer
* T1-T3, Nx, N0, N1, M0 disease
* Has undergone one- or two-stage total thyroidectomy with or without lymph node dissection
* All known tumor resected (R0)
* Requires radioiodine remnant ablation
* Does not require mandatory recombinant thyroid-stimulating hormone
* No Hurthle cell carcinoma or aggressive variants, including any of the following:
* Tall cell, insular, poorly differentiated disease with diffuse sclerosing
* Anaplastic or medullary carcinoma
PATIENT CHARACTERISTICS:
* WHO performance status 0-2
* No severe comorbid conditions including, but not limited to, any of the following:
* Unstable angina
* Recent heart attack or stroke
* Severe labile hypertension
* Dementia
* Concurrent dialysis
* Tracheostomy needing care
* Learning difficulties
* Inability to comply with radiation protection issues
* Requirement for frequent nursing or medical supervision that puts staff at risk for unacceptable radiation exposure
* No other cancers except basal cell skin cancer or carcinoma in situ of the cervix
* Not pregnant or nursing
* Negative pregnancy test
* Fertile female patients must use effective contraception during and for 6 months after radioiodine remnant ablation
* Fertile male patients must use effective contraception during and for 4 months after radioiodine remnant ablation
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* More than 3 months since prior contrast CT scan
* No prior iodine I 131 or iodine I 123 pre-ablation scan
* No prior treatment for thyroid cancer (except surgery)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
80 Years
Study:
NCT00415233
Study Brief:
Protocol Section:
NCT00415233